Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever

[1]  P. Nsubuga,et al.  Mortality Among Confirmed Lassa Fever Cases During the 2015-2016 Outbreak in Nigeria , 2018, American journal of public health.

[2]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .

[3]  Donald S. Grant,et al.  Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever , 2017, Nature Medicine.

[4]  K. Chandran,et al.  Structural basis for antibody-mediated neutralization of Lassa virus , 2017, Science.

[5]  S. Plotkin.  Vaccines for epidemic infections and the role of CEPI , 2017, Human vaccines & immunotherapeutics.

[6]  Dafna M. Abelson,et al.  Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection. , 2016, The Journal of infectious diseases.

[7]  D. Srikrishna,et al.  Overlooking the importance of immunoassays. , 2016, The Lancet. Infectious diseases.

[8]  Pardis C Sabeti,et al.  Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits , 2016, Nature Communications.

[9]  Virgil L. Woods,et al.  Crystal Structure of the Oligomeric Form of Lassa Virus Matrix Protein Z , 2016, Journal of Virology.

[10]  Epidemic focus: Lassa Fever. , 2016, Releve epidemiologique hebdomadaire.

[11]  R. Garry,et al.  Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection. , 2016, The Journal of infectious diseases.

[12]  Christl A. Donnelly,et al.  The role of rapid diagnostics in managing Ebola epidemics , 2015, Nature.

[13]  N. Forrester,et al.  Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage , 2015, Front. Microbiol..

[14]  T. Boyles,et al.  Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. , 2015, The Lancet. Infectious diseases.

[15]  A. Harries,et al.  The WHO clinical case definition for suspected cases of Ebola virus disease arriving at Ebola holding units: reason to worry? , 2015, The Lancet. Infectious diseases.

[16]  M. J. Broadhurst,et al.  ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study , 2015, The Lancet.

[17]  Elizabeth M. Ryan,et al.  Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus , 2015, Cell.

[18]  S. Günther,et al.  International External Quality Assessment Study for Molecular Detection of Lassa Virus , 2015, PLoS neglected tropical diseases.

[19]  Dafna M. Abelson,et al.  Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak. , 2015, Viral immunology.

[20]  G. Forrest,et al.  Review of rapid diagnostic tests used by antimicrobial stewardship programs. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Pardis C Sabeti,et al.  Lassa Fever in Post-Conflict Sierra Leone , 2014, PLoS neglected tropical diseases.

[22]  Pardis C Sabeti,et al.  Molecular Diagnostics for Lassa Fever at Irrua Specialist Teaching Hospital, Nigeria: Lessons Learnt from Two Years of Laboratory Operation , 2012, PLoS neglected tropical diseases.

[23]  Donald S. Grant,et al.  Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection , 2011, Virology Journal.

[24]  Pardis C Sabeti,et al.  Lassa hemorrhagic fever in a late term pregnancy from northern sierra leone with a positive maternal outcome: case report , 2011, Virology Journal.

[25]  James E. Robinson,et al.  Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: Case Report , 2011, Virology Journal.

[26]  R. D. Allen,et al.  Evaluation of Lassa antiviral compound ST-193 in a guinea pig model , 2011, Antiviral Research.

[27]  D. Bausch,et al.  Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa Fever , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  A. MacNeil,et al.  Imported Lassa Fever, Pennsylvania, USA, 2010 , 2010, Emerging infectious diseases.

[29]  M. Nwegbu,et al.  Early-onset sensorineural hearing loss in Lassa fever , 2010, European Archives of Oto-Rhino-Laryngology.

[30]  S. Günther,et al.  Laboratory Diagnosis of Lassa Fever, Liberia , 2010, Emerging infectious diseases.

[31]  Augustine Goba,et al.  Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. , 2010, The American journal of tropical medicine and hygiene.

[32]  S. Günther,et al.  Improved Detection of Lassa Virus by Reverse Transcription-PCR Targeting the 5′ Region of S RNA , 2010, Journal of Clinical Microbiology.

[33]  T. Brooks,et al.  A fatal case of Lassa fever in London, January 2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[34]  R. Tesh,et al.  Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance , 2008, Virology Journal.

[35]  C. Roth,et al.  New opportunities for field research on the pathogenesis and treatment of Lassa fever. , 2008, Antiviral research.

[36]  J. T. ter Meulen,et al.  Reproductive characteristics of Mastomys natalensis and Lassa virus prevalence in Guinea, West Africa. , 2008, Vector borne and zoonotic diseases.

[37]  M. Wolfe,et al.  Historical Lassa Fever Reports and 30-year Clinical Update , 2006, Emerging infectious diseases.

[38]  C. Drosten,et al.  False-Negative Results of PCR Assay with Plasma of Patients with Severe Viral Hemorrhagic Fever , 2002, Journal of Clinical Microbiology.

[39]  J. McCormick,et al.  Lassa fever. , 2002, Current topics in microbiology and immunology.

[40]  T. Ksiazek,et al.  Lassa fever in Guinea: II. Distribution and prevalence of Lassa virus infection in small mammals. , 2001, Vector borne and zoonotic diseases.

[41]  T. Ksiazek,et al.  Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. , 2001, Vector borne and zoonotic diseases.

[42]  Stuart T. Nichol,et al.  Genetic Diversity among Lassa Virus Strains , 2000, Journal of Virology.

[43]  T. Ksiazek,et al.  Diagnosis and Clinical Virology of Lassa Fever as Evaluated by Enzyme-Linked Immunosorbent Assay, Indirect Fluorescent-Antibody Test, and Virus Isolation , 2000, Journal of Clinical Microbiology.

[44]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[45]  D. Brown,et al.  Early diagnosis of Lassa fever by reverse transcription-PCR , 1994, Journal of clinical microbiology.

[46]  J. McCormick,et al.  Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. , 1993, The American journal of tropical medicine and hygiene.

[47]  Kopf und Halschirurgie Deutsche Gesellschaft für Hals-Nasen-Ohrenheilkunde.  European archives of oto-rhino-laryngology , 1990 .

[48]  J. Huggins.  Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. , 1989, Reviews of infectious diseases.

[49]  J. B. McCormick,et al.  A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. , 1988, BMJ.

[50]  J. McCormick,et al.  A case-control study of the clinical diagnosis and course of Lassa fever. , 1987, The Journal of infectious diseases.

[51]  E. S. Smith,et al.  A prospective study of the epidemiology and ecology of Lassa fever. , 1987, The Journal of infectious diseases.

[52]  J. McCormick,et al.  SAFE INTENSIVE-CARE MANAGEMENT OF A SEVERE CASE OF LASSA FEVER WITH SIMPLE BARRIER NURSING TECHNIQUES , 1985, The Lancet.

[53]  P. Jahrling,et al.  Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay , 1984, Journal of clinical microbiology.

[54]  J. McCormick,et al.  Pathologic and virologic study of fatal Lassa fever in man. , 1982, The American journal of pathology.

[55]  A. Anusz.  [Lassa fever]. , 1981, Pielegniarka i polozna.

[56]  J. V. Lange,et al.  Indirect immunofluorescence for the diagnosis of Lassa fever infection. , 1975, Bulletin of the World Health Organization.

[57]  T. Monath,et al.  Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. , 1974, The American journal of tropical medicine and hygiene.